SGLT2

Joseph J, Dinesh D, Chandran C, L D, Dharan SS. The impact of Empagliflozin on chronic kidney disease patient regardless of diabetes: A review. Asian Journal of Pharmaceutical and Health Sciences. 2025;14(4):3036-3040.